Chapter 1. BIOLOGICAL IMPLANTS MARKET– Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. BIOLOGICAL IMPLANTS MARKET– Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-112 Impact Analysis
2.3.1. Impact during 2023 – 2030
2.3.2. Impact on Supply – Demand
Chapter 3. BIOLOGICAL IMPLANTS MARKET– Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. BIOLOGICAL IMPLANTS MARKET- Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. BIOLOGICAL IMPLANTS MARKET- Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. BIOLOGICAL IMPLANTS MARKET– By Type of Bio-Implants
6.1. Cardiovascular Implants
6.2. Dental Implants
6.3. Spinal Bio-implants
6.4. Orthopaedic Implants
6.5. Ophthalmic Implants
6.6. Others
Chapter 7. BIOLOGICAL IMPLANTS MARKET– By Material
7.1. Metallic
7.2. Ceramic
7.3. Polymer
7.4. Biological
Chapter 8. BIOLOGICAL IMPLANTS MARKET– By Origin
8.1. Allograft
8.2. Autograft
8.3. Xenograft
8.4. Synthetic
Chapter 9. BIOLOGICAL IMPLANTS MARKET– By Mode of Administration
9.1. Non Surgical
9.2. Surgical
Chapter 10. BIOLOGICAL IMPLANTS MARKET– By End-User
10.1. Ambulatory Surgical Centers
10.2. Clinics
10.3. Hospital
10.4. Others
Chapter 11. BIOLOGICAL IMPLANTS MARKET– By Region
11.1. North America
11.2. Europe
11.3. The Asia Pacific
11.4. Latin America
11.5. Middle-East and Africa
Chapter 12. BIOLOGICAL IMPLANTS MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
12.1. Company 1
12.2. Company 2
12.3. Company 3
12.4. Company 4
12.5. Company 5
12.6. Company 6
12.7. Company 7
12.8. Company 8
12.9. Company 9
12.10. Company 10
2850
5250
4500
1800